AIM HIGHer CLINICAL STUDY
Explore a clinical study for people living with heart failure
The AIM HIGHer study is a FDA approved clinical research study designed to evaluate the safety and effectiveness of a therapy called Cardiac Contractility Modulation (CCM®) in people who have heart failure and ongoing symptoms despite medical treatment. This therapy is being studied to better understand how it may help certain people with heart failure.
What is heart failure?
Heart failure occurs when the heart muscle can’t pump blood as well as it should. This can lead to a buildup of fluid in the body and reduced oxygen supply to your organs and tissues.
Shortness of breath during activity or at rest
Fatigue or low energy
Swelling in legs or abdomen
Weight gain from fluid retention
Dizziness or difficulty concentrating
These symptoms may persist even when you are on medications.
What is CCM® therapy?
Eligible enrolled participants receive an implanted device delivering electrical signals to the heart muscle during each heartbeat.
Implanted under the skin in either the right or left pectoral area
Uses two small wires connected to the heart
Rechargeable and designed for long-term use
The study explains the procedures, risks and alternatives before a decision to participate.
Could you be eligible?
The study may be a good fit for you if you meet the following basic criteria:
18 years or older
Diagnosed with heart failure
Ongoing symptoms despite treatment
Ejection fraction between 40% and 70%, assessed by cardiologist via echocardiogram
Further eligibility is determined through medical testing and review after consent.
Why consider participating?
Limited treatment options for this type of heart failure
Continue standard medical care from your doctor
May help researchers better understand future treatment options
Closely monitored by specialized heart teams
Participation is voluntary and you may leave at any time
Early access to new heart failure technology and therapies
Clinical study participants may not all experience benefit and may experience risk-related complications.
What can I expect in the study?
1
Screening tests
Confirm eligibility and complete baseline tests.
2
Implantation
Implantation of a small device similar in size to a pacemaker.
3
Follow-up visits
Scheduled follow-up visits with study team and doctors.
4
Questionnaires
Questionnaires about health and symptoms.
The first phase lasts 18 months, with follow-up monitoring up to 5 years.
Frequently Asked Questions
Where is the study being conducted?
Up to 150 hospital centers across the USA, aiming to enroll up to 1,500 patients.
Will I need to pay for this?
The procedure and related costs may be covered by insurance; there may be out-of-pocket copays and Impulse Dynamics may cover a portion.
How can I get more info?
Complete a brief survey and, if qualified, connect with an Impulse Dynamics representative.
Take the next step
Find out if you may be eligible for the AIM-HIGHer clinical study.
